Nicotine Promotes Proliferation of Human Nasopharyngeal Carcinoma Cells by Regulating α7AChR, ERK, HIF-1α and VEGF/PEDF Signaling

Nicotine, the major component in cigarette smoke, can promote tumor growth and angiogenesis, but the precise mechanisms involved remain largely unknown. Here, we investigated the mechanism of action of nicotine in human nasopharyngeal carcinoma (NPC) cells. Nicotine significantly promoted cell proliferation in a dose and time-dependent manner in human NPC cells. The mechanism studies showed that the observed stimulation of proliferation was accompanied by the nicotine-mediated simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling. Treatment of NPC cells with nicotine markedly upregulated the expression of alpha 7AChR and HIF-1 alpha proteins. Transfection with a alpha 7AChR or HIF-1 alpha-specific siRNA or a alpha 7AChR-selective inhibitor significantly attenuated the nicotine-mediated promotion of NPC cell proliferation. Nicotine also promoted the phosphorylation of ERK1/2 but not JNK and p38 proteins, thereby induced the activation of ERK/MAPK signaling pathway. Pretreatment with an ERK-selective inhibitor effectively reduced the nicotine-induced proliferation of NPC cells. Moreover, nicotine upregulated the expression of VEGF but suppressed the expression of PEDF at mRNA and protein levels, leading to a significant increase of the ratio of VEGF/PEDF in NPC cells. Pretreatment with a alpha 7AChR or ERK-selective inhibitor or transfection with a HIF-1 alpha-specific siRNA in NPC cells significantly inhibited the nicotine-induced HIF-1 alpha expression and VEGF/PEDF ratio. These results therefore indicate that nicotine promotes proliferation of human NPC cells in vitro through simultaneous modulation of alpha 7AChR, HIF-1 alpha, ERK and VEGF/PEDF signaling and suggest that the related molecules such as HIF-1 alpha might be the potential therapeutic targets for tobacco-associated diseases such as nasopharyngeal carcinomas.